Less invasive parotid tumor surgery may reduce nerve damage risk
NCT ID NCT07185542
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This completed trial compared two surgical techniques for removing benign parotid gland tumors: the standard superficial parotidectomy and a newer, less invasive intracapsular parotidectomy. The study involved 120 adults aged 20-65 with confirmed benign tumors. The goal was to see if the less invasive approach could reduce complications like facial nerve damage while still preventing tumor recurrence.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- surgical procedure
- What this could lead to
- If successful, this could show that a less invasive surgery for benign parotid tumors reduces complications like facial nerve damage while still effectively removing the tumor.
- What could go wrong
- This is a single completed trial with 120 participants, so results may not apply to all patients. The less invasive approach may have a higher risk of tumor recurrence.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN PAROTID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Al-Azhar university
Madīnat an Naşr, Cairo Governorate, 4450113, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.